RxDoctor Payments Data

Jessica Schmid, NP

Nurse Practitioner · Madison, WINPI 1124695457

Payments from drug & device makers

$1,990in general payments, 2019–2025

Across 32 payments — averaging $62.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$629
  • Johnson & Johnson$415
  • Abbott$201
  • Biosense Webster, Inc.$138
  • Boston Scientific$134
  • Biotronik Inc.$133
  • plus $340 from 3 others

What the payments were for

  • Travel & lodging$50%
  • Food & beverage$1,986100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,990 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Medicare billing

Part B allowed, 2024
$6,146
Medicare patients
65
Services billed
88

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban129$105,924
XareltoRivaroxaban24$26,665
Flecainide Acetate36$1,555
Dofetilide15$1,321
Amiodarone Hcl61$1,165
Metoprolol Succinate61$959
Mexiletine Hcl11$816
Diltiazem 24hr Er (Cd)Diltiazem Hcl16$309
Digoxin12$289
Metoprolol Tartrate31$251
Sucralfate18$234
ClopidogrelClopidogrel Bisulfate25$197
Pantoprazole Sodium32$164
Furosemide15$162
Atorvastatin Calcium14$118

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$100$105,924129 claims
Johnson & JohnsonXarelto$415$26,66524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

Other nurse practitioner in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →